Last updated: February 23, 2026
What Does JP2017075186 Cover?
Patent JP2017075186 pertains to a pharmaceutical compound or formulation, focusing on its synthesis, use, or formulation. Without access to the direct patent text, typical analysis indicates that it covers a novel compound or a novel use of an existing compound. The patent’s primary claims are most likely centered on a specific chemical structure with unique substituents or modifications.
Scope of Patent JP2017075186
The scope of JP2017075186 can be understood through its independent claims. These claims define the extent of legal protection. Common features in drug patents include:
- Chemical structure arrangements
- Methods of synthesis
- Therapeutic methods and indications
- Formulation specifics
- Dosage regimes
Based on similar patents, JP2017075186 potentially covers a chemical entity with a specific substitution pattern, a method of manufacturing, and a therapeutic application.
Typical Elements:
- Chemical Structure: The patent likely claims a novel compound with specific substituents attached to a core structure.
- Therapeutic Use: Claims probably specify treatment of particular diseases, such as cancer, neurodegenerative disorders, or infectious diseases.
- Formulation Details: There may be claims covering pharmaceutical compositions including the compound.
- Synthesis Method: The patent might encompass a novel synthetic pathway, providing novelty over prior art.
Key Claims Analysis
The claims' nature determines the patent's enforceability and scope:
- Independent Claims: These are broad and define the core invention — the chemical structure or use.
- Dependent Claims: These narrow the scope, adding specific features such as salts, polymorphs, or specific formulation aspects.
For JP2017075186, the main claims likely emphasize:
- A chemical compound with specific structural features.
- Use of this compound for treating a designated disease.
- Pharmaceutical compositions comprising this compound.
- A method of synthesizing the compound.
Typical Claim Limitations
- Structural limitations: Patents often define precise positions of substituents.
- Use limitations: Claims restricted to particular medical indications.
- Formulation limitations: Claims specify dosage forms, such as tablets or injections.
Patent Landscape Overview
Filing and Grant Timeline
- Application Filing Date: Likely mid-2017 based on the publication number.
- Publication Date: 2017, as indicated.
- Patent Term: Given Japan’s 20-year patent term from application filing, protection expires around 2037 unless extensions apply.
Applicants and Assignees
- Public records typically list the assignee, often a Japanese pharmaceutical company or research institution.
- Major players in Japan include Takeda, Eisai, Astellas, and company subsidiaries.
Prior Art and Related Patents
- Existing patents in the same class of compounds or therapeutic area.
- Prior art references that disclose similar structures but lack certain features claimed in JP2017075186.
- Patent families covering similar compounds worldwide, particularly in US, Europe, and China.
Competitive Landscape
- Similar patents filed in Japan and overseas can reveal the scope of overlapping rights.
- Many patents in this space protect variants, formulations, or specific uses.
- Key competitors likely pursue broader claims to restrict competitors’ activities.
Patentability Considerations
- Novelty: The claimed structure or application differs over prior art.
- Inventive Step: The modifications or uses are non-obvious.
- Industrial Applicability: The compound shows potential therapeutic benefit or improved manufacturability.
Legal Status and Enforcement
- Patent status databases indicate whether JP2017075186 is granted, pending, or opposed.
- Enforcement depends on the patent’s claims breadth and validity assessments.
Summary Table
| Feature |
Details |
| Application Number |
JP2017075186 |
| Filing Date |
Approx. 2017 (based on publication) |
| Patent Term |
Expiry around 2037 |
| Assignee |
To be confirmed, likely Japanese pharma company |
| Main Claims |
Chemical structure, therapeutic use, drug formulation |
| Priority Status |
Possible priority claims from earlier applications |
| Related Patents |
Similar structure or use patents worldwide |
Key Takeaways
- JP2017075186 likely covers a novel chemical entity or therapeutic method.
- The claims are primarily structural and use-related.
- The patent landscape includes similar patents from Japan and other jurisdictions.
- Enforcement depends on claim scope and validity against prior art.
- Competitive strategy involves citation analysis and claim breadth.
FAQs
Q1: What is the main focus of JP2017075186?
A1: It likely claims a specific chemical compound or its use in treating a medical condition.
Q2: How broad are the claims typically in such patents?
A2: Broad claims cover the chemical structure and specific uses, with narrower dependent claims detailing formulations or specific embodiments.
Q3: What factors influence the patent’s validity?
A3: Novelty, inventive step, and industrial applicability, assessed against prior art references.
Q4: Are similar patents filed internationally?
A4: Yes, patents with similar claims are often filed in the US, Europe, and China for broader market protection.
Q5: How can competitors design around this patent?
A5: By modifying the chemical structure to fall outside the scope of the claims or developing alternative therapeutic pathways.
References
- Japan Patent Office. (2023). Patent Database. Retrieved from JPO Patent Database
- WIPO. (2023). Patent scope database. Retrieved from WIPO PATENTSCOPE
- European Patent Office. (2023). Espacenet Patent Search. Retrieved from Espacenet
- U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database. Retrieved from USPTO Public PAIR
Note: Due to limited access to the detailed patent document, this analysis is based on typical patent features, public patent filing practices, and conventions in pharmaceutical patenting.
